February 24, 2010 - The American College of Radiology Task Force on Radiation Dose in Medicine will testify before the House Energy and Commerce Health Subcommittee on February 26 that ACR accreditation programs can help prevent adverse events related to radiation oncology procedures and CT scans.

The hearing stems from recent media reports regarding adverse events related to radiation oncology procedures and CT scans performed at various hospitals.
At the hearing, E. Stephen Amis, M.D., FACR, chair of the American College of Radiology Task Force on Radiation Dose in Medicine will affirm that ACR accreditation of diagnostic modalities and the joint ACR/ASTRO accreditation program for radiation oncology facilities can significantly reduce the odds of such events and will call for mandatory accreditation of all advanced imaging and radiation oncology providers regardless of setting.
The Centers for Medicare and Medicaid Services will require accreditation of all facilitates that bill for advanced imaging (MRI, CT, PET and nuclear medicine exams) under part B of the Medicare Physician Fee Schedule effective Jan. 1, 2012. However, this requirement does not apply to hospital providers of these services and does not include radiation oncology.

Dr. Amis will stress that radiation oncology and medical imaging save and extend countless lives each year and represent critical advances in patient care. He will also relate that while the rare adverse events highlighted in recent media reports are unfortunate and require review to help ensure such mistakes are not repeated, the overwhelming majority of patients safely receive the correct care.
Dr. Amis will also emphasize that expanded use of ACR Appropriateness Criteria can help ensure that patients get appropriate care. He will also highlight the College’s efforts to reduce radiation dose from medical imaging and reinforce the need for substantive and standardized manufacturer education for radiation therapists and technologists who operate equipment.

He will also express ACR’s support of HR 3652, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy (CARE) Act. Introduced by Energy and Commerce Committee Member John Barrow (D-GA) and cosponsored by several of his colleagues on the Committee, the bill sets minimum federal standards for training and credentialing of radiation therapists, technicians, and other personnel who perform or plan the technical component of either medical imaging examinations or radiation therapy procedures.

For more information: www.acr.org or [email protected].


Related Content

News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | X-Ray

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
News | Imaging Software Development

April 28, 2026 — Avatar Medical has been granted FDA 510(k) clearance for Avatar Medical Vision, its software platform ...

Time April 28, 2026
arrow
News | Cardiac Imaging

April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...

Time April 28, 2026
arrow
News | Contrast Agents

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
Subscribe Now